845 related articles for article (PubMed ID: 10666429)
1. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
2. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
3. Human antibody response to surface layer proteins in Clostridium difficile infection.
Drudy D; Calabi E; Kyne L; Sougioultzis S; Kelly E; Fairweather N; Kelly CP
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):237-42. PubMed ID: 15196573
[TBL] [Abstract][Full Text] [Related]
4. Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.
Katchar K; Taylor CP; Tummala S; Chen X; Sheikh J; Kelly CP
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):707-13. PubMed ID: 17544998
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
7. [Yield of detection of Clostridium difficile toxin versus stool culture in the study of nosocomial diarrhea].
Rabasa M; Aguado JM; Lizasoaín M; Pedraza MA; Arribas P; Lumbreras C; Otero JR; Noriega AR
Enferm Infecc Microbiol Clin; 1993 Nov; 11(9):479-81. PubMed ID: 8305554
[TBL] [Abstract][Full Text] [Related]
8. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
9. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.
Kyne L; Warny M; Qamar A; Kelly CP
Lancet; 2001 Jan; 357(9251):189-93. PubMed ID: 11213096
[TBL] [Abstract][Full Text] [Related]
10. Host and pathogen factors for Clostridium difficile infection and colonization.
Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
[TBL] [Abstract][Full Text] [Related]
11. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.
Hourigan SK; Chirumamilla SR; Ross T; Golub JE; Rabizadeh S; Saeed SA; Elson CO; Kelly CP; Carroll KC; Oliva-Hemker M; Sears C
Inflamm Bowel Dis; 2013 Dec; 19(13):2744-52. PubMed ID: 24145927
[TBL] [Abstract][Full Text] [Related]
13. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile: development of a novel candidate vaccine.
Foglia G; Shah S; Luxemburger C; Pietrobon PJ
Vaccine; 2012 Jun; 30(29):4307-9. PubMed ID: 22682287
[TBL] [Abstract][Full Text] [Related]
15. Active and passive immunization against Clostridium difficile diarrhea and colitis.
Giannasca PJ; Warny M
Vaccine; 2004 Feb; 22(7):848-56. PubMed ID: 15040937
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
Ruby R; Magdesian KG; Kass PH
J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
[TBL] [Abstract][Full Text] [Related]
18. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.
Johnson S; Gerding DN; Janoff EN
J Infect Dis; 1992 Dec; 166(6):1287-94. PubMed ID: 1431247
[TBL] [Abstract][Full Text] [Related]
19. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
